2 -Adrenoceptor regulation of adenylyl cyclase in CHO cells: Dependence on receptor density, receptor subtype and current activity of adenylyl cyclase

By Pohjanoksa K.   Jansson C.c.   Luomala K.   Marjamaki A.   Savola J.-M.   Scheinin M.  

European Journal of Pharmacology, Vol. 335, Iss. 1, 1997-09 ,pp. : 53-63

Elsevier

Access to resources Recommend Favorite

β-adrenoceptor blocker treatment and the cardiac β-adrenoceptor-G-protein(s)-adenylyl cyclase system in chronic heart failure

By Brodde Otto-Erich  

Naunyn-Schmiedeberg's Archives of Pharmacology, Vol. 374, Iss. 5-6, 2007-02 ,pp. : 361-372

Springer Publishing Company

Access to resources Recommend Favorite

Ca 2+ -dependent sensitization of adenylyl cyclase activity

By Rousseau G.   Haddad P.S.   Gallo-Payet N.   Bouvier M.  

European Journal of Pharmacology, Vol. 422, Iss. 1, 2001-06 ,pp. : 53-60

Elsevier

Access to resources Recommend Favorite

Somatostatin coupling to adenylyl cyclase activity in the mouse retina

By Pavan Barbara   Fiorini Sara   Monte Massimo   Lunghi Laura   Biondi Carla   Bagnoli Paola   Cervia Davide  

Naunyn-Schmiedeberg's Archives of Pharmacology, Vol. 370, Iss. 2, 2004-08 ,pp. : 91-98

Springer Publishing Company

Access to resources Recommend Favorite

Regulation of pituitary adenylyl cyclase-activating polypeptide (PACAP, ADCYAP1: adenylyl cyclase-activating polypeptide 1) in the treatment of schizophrenia

By Matsuzaki Shinsuke   Tohyama Masaya  

Expert Opinion on Therapeutic Targets, Vol. 12, Iss. 9, 2008-09 ,pp. : 1097-1108

Informa Healthcare

Access to resources Recommend Favorite